Soltis Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Sell
3,157
-76
-2% -$5.99K 0.01% 521
2025
Q4
$265K Buy
3,233
+92
+3% +$7.17K 0.02% 428
2025
Q3
$236K Buy
3,141
+164
+6% +$12.2K 0.02% 426
2025
Q2
$220K Buy
2,977
+181
+6% +$12.6K 0.02% 367
2025
Q1
$226K Buy
2,796
+140
+5% +$12K 0.02% 335
2024
Q4
$208K Buy
2,656
+462
+21% +$39.3K 0.02% 349
2024
Q3
$206K Buy
+2,194
New +$184K 0.02% 345

Other funds holding GEHC

Soltis Investment Advisors's GEHC Position: Q1 2026 in Review

Soltis Investment Advisors reduced its GE HealthCare (GEHC) stake by 2.4% in Q1 2026, selling an estimated $5.99K and leaving 3,157 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #521.

Soltis Investment Advisors first reported a position in GEHC in Q3 2024 and has held it in 7 quarters since. The position peaked at $265K in Q4 2025. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Soltis Investment Advisors held 3,157 shares of GE HealthCare worth $225K as of Q1 2026.
  • Soltis Investment Advisors sold 76 GE HealthCare shares in Q1 2026, an estimated $5.99K.
  • GE HealthCare made up 0.01% of Soltis Investment Advisors's portfolio in Q1 2026, its #521 holding.
  • Soltis Investment Advisors first reported a position in GE HealthCare in Q3 2024 and has held it in 7 quarters since.
  • Soltis Investment Advisors's GE HealthCare position peaked at $265K in Q4 2025.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.